Please use this identifier to cite or link to this item: http://hdl.handle.net/10553/72732
DC FieldValueLanguage
dc.contributor.authorFederico, M.en_US
dc.contributor.authorPerez Fustero, A.en_US
dc.contributor.authorCatarina, C.en_US
dc.contributor.authorFernandez, I.en_US
dc.contributor.authorPerez Molina, J. L.en_US
dc.contributor.authorMorales Orue, I.en_US
dc.contributor.authorLloret Sáez-Bravo, Martaen_US
dc.date.accessioned2020-05-22T09:16:55Z-
dc.date.available2020-05-22T09:16:55Z-
dc.date.issued2019en_US
dc.identifier.issn0167-8140en_US
dc.identifier.otherWoS-
dc.identifier.urihttp://hdl.handle.net/10553/72732-
dc.description.abstractPurpose or Objective: Intracavitary/interstitial (IC/IS) brachytherapy (BT) improves HRCTV dose coverage in large locally advanced tumors resulting in improved local control and survival. In small tumors IC/IS brachytherapy may be useful in selected situations due to difficult OAR/tumor topography. A prospective trial was designed in order to evaluate in a series of consecutive patients with small cervical tumors potential gains of IC/IS vs. Intracavitary (IC) brachytherapyen_US
dc.languageengen_US
dc.relation.ispartofRadiotherapy and Oncologyen_US
dc.sourceRadiotherapy And Oncology [ISSN 0167-8140], v. 133 sup. 1, p. S85-S86, (Abril 2019)en_US
dc.subject320111 Radiologíaen_US
dc.titleDosimetric comparison of T-O brachytherapy with/without interstitial component in FIGO I-IIB tumorsen_US
dc.typeinfo:eu-repo/semantics/conferenceObjecten_US
dc.typeConference_Paperen_US
dc.relation.conference38th Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO)en_US
dc.identifier.doi10.1016/S0167-8140(19)30593-6en_US
dc.identifier.isi000468315600157-
dc.identifier.eissn1879-0887-
dc.description.lastpageS86en_US
dc.description.firstpageS85en_US
dc.relation.volume133en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Actas de congresosen_US
dc.contributor.daisngid2129395-
dc.contributor.daisngid30211064-
dc.contributor.daisngid23147274-
dc.contributor.daisngid6447172-
dc.contributor.daisngid29053950-
dc.contributor.daisngid30204855-
dc.contributor.daisngid802813-
dc.description.numberofpages2en_US
dc.utils.revisionen_US
dc.contributor.wosstandardWOS:Federico, M-
dc.contributor.wosstandardWOS:Fustero, AP-
dc.contributor.wosstandardWOS:Catarina, C-
dc.contributor.wosstandardWOS:Fernandez, I-
dc.contributor.wosstandardWOS:Molina, JLP-
dc.contributor.wosstandardWOS:Orue, IM-
dc.contributor.wosstandardWOS:Lloret, M-
dc.date.coverdateAbril 2019en_US
dc.identifier.supplement1-
dc.identifier.conferenceidevents121155-
item.grantfulltextnone-
item.fulltextSin texto completo-
crisitem.event.eventsstartdate26-04-2019-
crisitem.event.eventsenddate30-04-2019-
crisitem.author.deptDepartamento de Ciencias Clínicas-
crisitem.author.deptMedio Ambiente y Salud-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameLloret Sáez-Bravo, Marta-
crisitem.author.departamentoCiencias Clínicas-
Appears in Collections:Actas de congresos
Show simple item record

Page view(s)

5
checked on May 23, 2020

Google ScholarTM

Check

Altmetric


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.